Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The

    Published: January 1, 2006 | Price: $3,500.00 – $7,000.00

    The U.S. long-term care industry experienced strong growth from 1999 through 2004 and this growth is expected to continue through the end of the decade. Indeed, the aging of the U.S. population will push unprecedented demand for all forms of long-term care, but ongoing cost containment issues continue to pressure both private and public managed care organizations and make competition in this dynamic environment challenging. This comprehensive study from Kalorama Information details four segments of the long-term care industry, including:...
    Outsourcing in Drug Discovery, 2nd Edition

    Published: January 1, 2006 | Price: $2,995.00 – $5,990.00

    In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous changes that are taking place in the drug discovery outsourcing market, and the forces that are shaping the sector. It presents viewpoints from both customers...
    Advanced Drug Delivery – Technologies, Applications, and Markets, 2nd Ed.

    Published: November 15, 2005 | Price: $2,500.00 – $7,000.00

    This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, the report considers the options that the current technologies present, the progress that is being made in these fields, and the reception these new products...
    Worldwide Market for Pediatric Drugs, 2nd Edition, The

    Published: November 1, 2005 | Price: $3,500.00 – $7,000.00

    Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment of conditions and diseases affecting pediatrics and the healthy growth of children are vital to providing a solid foundation for healthy adults in the future....
    Market for Generic Biologics – Issues, Trends, and Market Potential, 2nd edition, The

    Published: November 1, 2005 | Price: $2,500.00 – $5,000.00

    Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% per year) to generic competition, if—and it’s a big if—the regulatory hurdles for these generics can be overcome. Biogeneric is a new term combining biologic...
    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    Published: November 1, 2005 | Price: $4,995.00 – $9,990.00

    There has not been a year in the last decade in which the IVD market in China has failed to grow. With a gross domestic product of over $1.4 trillion, China surpassed Italy last year to become the world’s sixth largest economy, according to the International Monetary Fund. This country of 1.3 billion people is now America’s sixth largest export market, and China’s economy, which has been growing at an average rate of 8% over the last 20 years, grew...
    World Market for Respiratory Equipment, The

    Published: November 1, 2005 | Price: $3,500.00 – $7,000.00

    Respiratory diseases are among the most common ailments across the world. Asthma and chronic obstructive pulmonary disease (COPD) are the major causes of mortality rates among children and elderly. Currently, about 300 million people suffer from asthma—the number only expected to rise over next few years—and about 14.2 million people suffer from COPD. Given these numbers, it’s no wonder that the market for respiratory products is buoyant. This report analyzes the worldwide market for respiratory disposables and reusables, including the...
    Worldwide Market for Cancer Diagnostics, The

    Published: October 1, 2005 | Price: $3,500.00 – $7,000.00

    Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are making continued progress in understanding the disease. Further, cancer drug research is moving from traditional cytotoxic chemotherapies toward higher specificity immunological and biological approaches that...
    U.S. Market for Clinical Information Systems – An Analysis of the Growing Use of Information Technology for Hospital-Based Patient Care, The

    Published: October 1, 2005 | Price: $895.00 – $5,990.00

    Information technology (IT) has the potential to improve the quality, safety and efficiency of clinical care. IT is not new to the hospital setting. Computers and software have been used for many years to improve the paper-based administrative functions of hospital support staff, such as scheduling and billing. But the use of IT in the clinical setting to optimize, streamline and simplify patient records, testing, imaging and operating room procedures has lagged behind its medical administrative applications. The evolution of...
    Implant-Based Dental Reconstruction – The Worldwide Implant and Bone Graft Market

    Published: September 1, 2005 | Price: $995.00 – $7,000.00

    In the industrial world, over 240 million people lack one or more teeth. It is estimated that 40% of the western population is missing one tooth or more. In the United States, approximately 10% is the population is totally edentulous, and every year about two million Americans loose a tooth due to sporting accidents. Although the success of modern dentistry in the United States has vastly decreased the edentulous rate in each succeeding generation, it is estimated there are about...
    The U.S. Market For Cardiovascular Devices

    Published: September 1, 2005 | Price: $3,500.00 – $7,000.00

    This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the American population, e.g., stroke and myocardial infarction, these four conditions present the core conditions that lead to more serious cardiovascular accidents and death and present...
    Wound Care Markets, 2nd Edition, Vol III – Surgical and Trauma Wounds

    Published: September 1, 2005 | Price: $2,995.00 – $5,990.00

    Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed daily. Enjoying market success depends on developing a formidable strategy that involves matching internal capabilities with external opportunities. Providers who compete well in this area must offer products that achieve...
    The World Market for Neurotherapeutic Drugs

    Published: September 1, 2005 | Price: $3,500.00 – $7,000.00

    Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
    Glycosylated Protein Therapeutics – A Market Briefing

    Published: September 1, 2005 | Price: $795.00 – $1,590.00

    One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...
    Wound Care Markets, 2nd Edition, Vol II – Burns

    Published: August 1, 2005 | Price: $2,995.00 – $5,990.00

    Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address infection, pain, and a host of long-term complications. Continued advances in biotechnology have driven the burn portion of the wound care industry, estimated at over $1.5 billion globally. New wound...